High-Risk Skin Cancer Surveillance
High-risk skin cancer surveillance is structured, ongoing follow-up for people who have a higher-than-average risk of developing a new skin cancer or having a previous skin cancer return.

It is different from a one-time skin check.
Surveillance may include:
- Regular full-body skin examinations
- Examination of previous skin-cancer treatment sites
- Dermoscopy of selected moles or lesions
- Comparison with previous photographs
- Mole mapping or total-body photography in selected patients
- Monitoring of regional lymph nodes when clinically appropriate
- Skin self-examination between appointments
- Biopsy of lesions that become suspicious
- Additional imaging or specialist follow-up for selected patients with higher-stage cancers The frequency and intensity of follow-up should be individualized. For melanoma in particular, surveillance depends on the original stage, risk of recurrence and risk of developing another primary melanoma.
For Thai patients, expatriates, tourists and international patients in Bangkok, having a clear surveillance plan is especially useful when previous skin-cancer treatment or dermatology records come from another country.
What Is High-Risk Skin Cancer Surveillance?
Skin cancer surveillance is a planned process of repeatedly examining a patient over time rather than evaluating only one lesion at one appointment.
The goals are generally to identify:
- A new skin cancer
- Recurrence at a previously treated site
- A new melanoma in another location
- Changes in an existing mole
- New suspicious lesions
- Enlarged lymph nodes or other concerning findings when relevant
- Treatment-related problems requiring follow-up
For someone who has previously had melanoma, follow-up is particularly important because both recurrence and development of another melanoma are possible. Clinical guidelines recommend ongoing follow-up after melanoma, with the intensity of surveillance determined by disease stage and individual risk.
Is Surveillance the Same as Skin Cancer Screening?
Not exactly.
Skin cancer screening usually refers to examining someone for skin cancer before a diagnosis has been established.
Skin cancer surveillance usually refers to ongoing monitoring of someone whose risk is already known to be increased.
For example:
A person with no previous skin cancer who requests a first full-body examination is generally undergoing a skin check or screening examination.
Someone who has previously had melanoma and returns regularly for structured examinations is undergoing surveillance.
This distinction matters because higher-risk patients often need a more individualized follow-up strategy.
Who Is Considered High Risk for Skin Cancer?
There is no single definition that applies to every skin-cancer type, but surveillance is especially relevant for people with factors such as:
- Previous melanoma
- Previous basal cell carcinoma
- Previous cutaneous squamous cell carcinoma
- Multiple previous skin cancers
- Numerous moles
- Multiple atypical or dysplastic moles
- Strong family history of melanoma
- Significant cumulative ultraviolet exposure
- Repeated severe sunburns
- Marked sun damage
- Reduced immune function
- Organ transplantation or use of immune-suppressing medication
- Certain inherited cancer-predisposition syndromes
- A history of high-risk or recurrent skin cancer
People with previous basal cell or squamous cell carcinoma also have an increased risk of developing additional skin cancers and require continued skin examinations.
Previous Melanoma
A history of melanoma is one of the clearest reasons for long-term skin surveillance.
Follow-up has two important purposes:
- Looking for recurrence of the previous melanoma
- Looking for another new primary melanoma or another type of skin cancer Follow-up frequency after melanoma depends on the original stage, recurrence risk and risk of developing another melanoma.
Lifelong skin follow-up is generally recommended after melanoma.
Previous Basal Cell Carcinoma
Basal cell carcinoma usually behaves very differently from melanoma, but follow-up remains important.
After having one basal cell carcinoma, a patient has an increased likelihood of developing another skin cancer later.
Standard guidelines recommend annual examinations after basal cell carcinoma to look for recurrence and new primary skin cancers.
In practice, the appropriate interval can be adjusted depending on factors such as:
- Number of previous tumors
- Tumor location
- Treatment received
- Recurrence history
- Degree of sun damage
- Other skin cancers
- Immune status
Follow-up after basal cell carcinoma is commonly around every 6 to 12 months, although schedules vary according to individual circumstances.
Previous Squamous Cell Carcinoma
Patients who have had cutaneous squamous cell carcinoma also require ongoing monitoring.
At least annual examination is recommended for recurrence and new primary skin cancers after a diagnosis of cutaneous squamous cell carcinoma.
Some patients require more frequent follow-up.
Follow-up after squamous cell carcinoma is often every 3 to 6 months for the first few years, with longer intervals later when appropriate; higher-risk tumors generally require closer surveillance.
Multiple Previous Skin Cancers
A patient who has developed several independent skin cancers may require a different approach from someone who has had a single low-risk lesion.
Surveillance may need to focus on:
- New lesions anywhere on the body
- Previously treated areas
- Areas of severe sun damage
- Rapidly appearing keratinizing lesions
- Changing pigmented lesions
- Treatment scars
- Field changes such as multiple actinic keratoses
The interval should be individualized rather than applying a single schedule to all patients.
Numerous or Atypical Moles
Patients with many moles can be challenging to monitor because simply remembering the appearance of every lesion is difficult.
Surveillance may involve:
- Full-body examination
- Dermoscopy
- Identifying the patient’s usual mole pattern
- Looking for an “ugly duckling” lesion
- Baseline photography
- Sequential photographic comparison
Total-body photography can be particularly useful for high-risk patients with numerous or atypical moles.
Strong Family History of Melanoma
A family history can increase concern, particularly when:
- Several close relatives have melanoma
- Melanoma occurred at a young age
- One person has developed multiple primary melanomas
- There is a known inherited cancer-predisposition mutation
- Melanoma occurs together with a pattern of other cancers in the family Not every patient with one relative who had melanoma requires genetic testing.
However, unusually strong family patterns may justify specialist assessment and, in selected cases, genetic counseling.
Immunosuppression
Reduced immune function can significantly alter skin-cancer risk.
Examples include patients who:
- Have undergone organ transplantation
- Take long-term immune-suppressing medication
- Have certain hematologic diseases
- Have other conditions associated with reduced immune surveillance These patients can develop multiple skin cancers, especially squamous cell carcinoma, and may require closer dermatologic follow-up than the general population.
People taking immune-suppressing medication, including organ-transplant recipients, are an important group for skin self-surveillance and professional examination.
What Does a High-Risk Surveillance Appointment Include?
The examination should be adapted to the reason the patient is considered high risk.
A typical visit may involve:
- Reviewing previous skin-cancer diagnoses
- Reviewing pathology reports
- Asking about new or changing lesions
- Asking about new symptoms
- Examining previous treatment scars
- Full-body skin examination
- Dermoscopy of selected lesions
- Comparing lesions with previous photographs
- Examining regional lymph nodes when clinically appropriate
- Deciding whether any lesion requires biopsy
- Planning the next follow-up interval
Melanoma follow-up potentially includes general skin examination, assessment of the previous melanoma scar, lymph-node examination and sequential photography or dermoscopy in patients with many or atypical moles.
Full-Body Skin Examination
A high-risk surveillance visit should not focus only on the location where a previous cancer was removed.
New skin cancers can develop elsewhere.
A systematic examination may include:
- Scalp
- Face
- Ears
- Neck
- Chest
- Abdomen
- Back
- Arms
- Hands
- Fingernails
- Buttocks
- Legs
- Feet
- Soles
- Between the toes
- Toenails
Other areas may be examined when clinically indicated.
It is recommended to establish what is normal for the individual and look for solitary lesions that differ from the patient’s overall skin pattern.
Examination of Previous Skin-Cancer Scars
The treatment site should be reviewed because some skin cancers can recur locally.
The dermatologist may assess for:
- New pigmentation
- Nodules
- Thickening
- Ulceration
- Persistent crusting
- New bleeding
- Changes around the surgical scar
However, most scar changes are not necessarily recurrence.
Scar redness, thickening or altered pigmentation can also occur during normal healing.
If the appearance is uncertain, further evaluation may be appropriate.
Lymph-Node Examination
Lymph-node assessment is not necessary in the same way for every skin cancer.
It may be particularly relevant for:
- Melanoma
- Higher-risk squamous cell carcinoma
- Previous cancers known to have regional lymph-node involvement
- New symptoms or abnormal findings
Common lymph-node regions include:
- Neck
- Armpits
- Groin
After melanoma, follow-up visits may include examination of regional lymph nodes depending on the patient’s stage and risk.
Dermoscopy in High-Risk Surveillance
Dermoscopy uses a handheld magnifying instrument with specialized lighting to examine structures within a skin lesion that may not be visible to the naked eye.
It can help evaluate:
- Moles
- Atypical moles
- Melanoma
- Pigmented basal cell carcinoma
- Some non-pigmented skin cancers
- Lesions on palms and soles
- Nail pigmentation
For high-risk patients, its value is not simply examining a single suspicious mole.
It can also help establish an individual’s typical pattern and identify lesions that deviate from that pattern.
Does Every Mole Need Dermoscopy?
Not necessarily.
A dermatologist may recognize many clearly benign lesions clinically.
Dermoscopy is most useful when:
- A mole appears atypical
- A lesion is new or changing
- The diagnosis is uncertain
- One lesion differs from surrounding lesions
- The patient has a history of melanoma
- A lesion is being monitored over time
The decision depends on the patient’s overall risk and the lesion’s appearance.
Total-Body Photography
Total-body photography creates standardized baseline images of the skin.
During later visits, these images can help identify:
- New lesions
- Moles that disappeared
- Lesions that changed in size
- Changes in shape
- Changes in pigmentation
Photographic skin surveillance is especially useful for high-risk melanoma patients and people with many or atypical moles.
However, total-body photography is not necessary for every high-risk patient.
Mole Mapping
The term “mole mapping” is used in different ways.
A comprehensive monitoring program may include:
- Full-body photography
- Close-up photographs
- Dermoscopic photographs
- Clinical examination
- Digital storage for comparison
- Repeat imaging when appropriate
The purpose is not simply to photograph every mole.
The important value is the ability to identify new or changing lesions over time.
Sequential Digital Dermoscopy
Sometimes a lesion has mild atypical features but does not clearly require immediate biopsy.
In carefully selected cases, a dermoscopic photograph may be stored and compared with a later image.
The dermatologist looks for changes such as:
- Enlargement
- Altered shape
- New colors
- New pigment structures
- Increasing asymmetry
- New dots or globules
- Vascular changes
Short-term digital dermoscopic follow-up, commonly over several months, is one component of photographic surveillance programs.
However, a lesion that is clearly suspicious should not simply be monitored indefinitely.
Which Lesions Should Not Just Be Monitored?
Monitoring is not appropriate for every lesion.
A suspicious lesion may require prompt biopsy rather than photography alone.
This is particularly important for lesions that are:
- Rapidly growing
- Nodular
- Ulcerated
- Repeatedly bleeding
- Clearly changing
- Strongly suspicious clinically
- Strongly suspicious on dermoscopy
Suspicious or nodular melanocytic lesions should generally be excised rather than placed into routine dermoscopic monitoring.
What Is the “Ugly Duckling” Sign?
Most people have a recognizable personal mole pattern.
For example, a person’s moles might usually be:
- Small
- Light brown
- Round
- Similar in appearance
If one lesion is:
- Much darker
- Larger
- Irregular
- Multicolored
- Structurally different
it may deserve closer examination.
This concept is called the ugly duckling sign and is particularly helpful in people with numerous moles.
The ABCDE Warning Signs of Melanoma
Patients at increased melanoma risk should also understand the ABCDE approach.
A — Asymmetry
One half looks different from the other.
B — Border
The edges may be irregular, poorly defined or scalloped.
C — Color
There may be several colors within one lesion.
D — Diameter
Larger lesions deserve attention, although melanoma can be smaller than 6 millimeters.
E — Evolution
Any change in:
- Size
- Shape
- Color
- Surface
- Symptoms
may be important.
Evolution is particularly useful because high-risk surveillance is fundamentally about recognizing meaningful change over time.
Skin Self-Examination Between Visits
Professional surveillance does not replace self-examination.
Patients who have previously had melanoma are commonly advised to perform regular self-examinations of their skin and, when relevant, lymph-node areas.
Melanoma survivors are often advised to perform skin and lymph-node self-examination at least monthly.
Patients with previous basal cell or squamous cell carcinoma are also generally encouraged to examine their skin regularly.
How to Check Your Skin at Home
A self-examination should include areas that are easy to forget.
Check:
- Face
- Ears
- Scalp
- Neck
- Chest
- Abdomen
- Arms
- Underarms
- Hands
- Fingernails
- Back
- Buttocks
- Legs
- Feet
- Soles
- Between toes
- Toenails
Use:
- Good lighting
- A full-length mirror
- A handheld mirror
- Assistance from a partner when necessary
The goal is not to diagnose your own lesions.
It is to notice what is new or changing.
Should You Photograph Your Skin at Home?
Photographs can be helpful, particularly when trying to document a changing lesion.
They may record:
- Size
- Shape
- Color
- Location
However, home photography has limitations.
Differences in lighting, camera distance and angle can create false impressions of change.
For high-risk patients with numerous lesions, standardized medical photography may provide more reliable longitudinal comparison than casual photographs.
Warning Signs That Should Not Wait Until the Next Appointment
Surveillance schedules are useful, but a patient should not wait several months for a routine appointment when an important change appears.
Arrange earlier assessment if you notice:
- A rapidly changing mole
- A new irregular pigmented lesion
- A lesion that looks very different from the others
- Rapid growth
- Spontaneous bleeding
- Repeated crusting
- A non-healing sore
- New pigmentation within or near a previous melanoma scar
- A new firm lump under or near a scar
- A new enlarged lymph node
- Persistent unexplained pigmentation beneath a nail
- A changing lesion on the palm or sole
Any new concerning symptom in a patient with previous advanced melanoma should also be discussed with the treating medical team.
How Often Should High-Risk Patients Be Examined?
There is no single interval for all high-risk patients.
The correct schedule depends on:
- Type of previous skin cancer
- Stage
- Number of previous tumors
- Tumor characteristics
- Recurrence history
- Number of moles
- Presence of atypical moles
- Family history
- Immune status
- Ability to perform self-examination
- Reliability of follow-up
This is why statements such as “every high-risk patient needs a skin check every three months forever” are not medically appropriate.
Follow-Up After Melanoma
Melanoma surveillance is particularly stage-dependent.
Typical follow-up after completely removed early-stage melanoma includes physical examination approximately every 6 to 12 months for several years, while more advanced melanomas may require visits approximately every 3 to 6 months initially. Imaging may be considered in selected higher-risk patients.
Melanoma follow-up intensity depends on stage, recurrence risk and risk of another primary melanoma.
Therefore, a patient’s actual schedule should be based on their original pathology and treatment history.
Follow-Up After Basal Cell Carcinoma
Professional dermatological guidelines recommend annual examinations after basal cell carcinoma to look for recurrence and new primary skin cancers.
Some patients may need more frequent examination, particularly if they have:
- Multiple basal cell carcinomas
- Recurrent tumors
- Extensive sun damage
- Other skin cancers
- Immune suppression
- Difficult-to-monitor locations
The American Cancer Society notes that follow-up visits are commonly recommended about every 6 to 12 months, although the exact schedule varies.
Follow-Up After Squamous Cell Carcinoma
Patients who have had squamous cell carcinoma also require regular skin examinations.
At least annual follow-up is recommended after cutaneous squamous cell carcinoma.
Patients with higher-risk tumors may need considerably closer surveillance.
Typical follow-up visits are often every 3 to 6 months during the first few years, with less frequent visits later if appropriate.
Are Routine Scans Needed for Every High-Risk Patient?
No.
Skin-cancer surveillance does not automatically mean repeated computed tomography, magnetic resonance imaging or positron-emission tomography scans.
For many patients with early skin cancer, physical examination and skin surveillance are the main components of follow-up.
Imaging may be considered for selected patients based on factors such as:
- More advanced melanoma
- Higher-risk squamous cell carcinoma
- Previous lymph-node involvement
- Symptoms suggesting recurrence
- Abnormal physical examination findings
- Specific oncology follow-up recommendations
Routine imaging has limited value in many patients with early melanoma unless symptoms or clinical findings suggest recurrence.
Are Blood Tests Needed?
Not routinely for everyone.
Blood tests do not replace:
- Skin examination
- Clinical assessment
- Dermoscopy
- Biopsy of suspicious lesions
Some patients with advanced melanoma or other complex cancers may undergo laboratory testing as part of oncology follow-up.
The decision depends on the cancer stage and treating team’s plan rather than simply being classified as “high risk.
”
Does High-Risk Surveillance Prevent Skin Cancer?
Surveillance does not guarantee that another skin cancer will not develop.
Its purpose is primarily to improve monitoring and help identify suspicious changes at an appropriate time.
Risk reduction involves additional measures, especially ultraviolet protection.
These include:
- Seeking shade
- Avoiding intentional tanning
- Wearing protective clothing
- Using a broad-brimmed hat
- Using broad-spectrum sunscreen
- Reapplying sunscreen appropriately
- Avoiding unnecessary ultraviolet exposure
Patients who have already had skin cancer should continue sun-protective behavior even when surveillance examinations are normal.
Can Supplements Prevent Another Skin Cancer?
Patients should be cautious about claims that vitamins or supplements can prevent recurrence.
Dietary supplements have not been proven to prevent melanoma recurrence.
For patients with previous squamous cell carcinoma or multiple keratinocyte cancers, some preventive strategies may occasionally be considered by a clinician for selected individuals, but these should be individualized rather than self-prescribed.
What Happens If a New Suspicious Lesion Is Found?
The next step depends on the lesion.
Options may include:
- Dermoscopic examination
- Clinical photography
- Short-term monitoring
- Skin biopsy
- Complete excision
- Referral for additional treatment
A lesion that appears suspicious for melanoma generally requires tissue diagnosis rather than indefinite observation.
Does Biopsy Mean the Cancer Has Returned?
No.
Biopsy means that the lesion cannot be confidently classified without microscopic examination.
Possible biopsy results include:
- Benign mole
- Atypical mole
- Seborrheic keratosis
- Actinic keratosis
- Basal cell carcinoma
- Squamous cell carcinoma
- Melanoma
- Another benign or malignant condition
Surveillance inevitably identifies some lesions that look suspicious but prove benign.
That does not mean the biopsy was unnecessary.
Recurrence Versus a New Primary Skin Cancer
These terms are different.
Recurrence means the original skin cancer has returned.
New primary skin cancer means an entirely new cancer has developed independently.
A patient who previously had melanoma, for example, may later develop:
- Recurrence of the previous melanoma
- A new melanoma
- Basal cell carcinoma
- Squamous cell carcinoma
This is one reason surveillance should examine the entire skin surface, not simply the old surgical scar.
High-Risk Surveillance in Asian Skin
Skin cancer can occur in people of every skin tone.
In Asian and darker skin types, particular attention may be required for:
- Soles
- Palms
- Nails
- Acral areas
- Persistent non-healing lesions
Melanoma in these locations may not necessarily be related to cumulative sun exposure in the same way as many melanomas in very fair skin.
A surveillance examination should therefore be adapted to the patient’s skin type rather than simply focusing on sun-exposed areas.
Skin Cancer Surveillance in Bangkok and Thailand
Bangkok’s international population means that dermatologists may see patients whose previous skin cancers were diagnosed and treated in many different countries.
For continuity of care, patients should ideally bring:
- Pathology reports
- Previous biopsy results
- Operative reports
- Melanoma stage information
- Previous photographs
- Mole-mapping records
- Dermoscopic images
- Oncology summaries
- Details of previous radiation or systemic treatment
A statement such as “I had melanoma removed several years ago” is useful, but the original pathology report provides much more information for planning appropriate surveillance.
What If Your Previous Records Are From Another Country?
Bring whatever documentation is available.
Useful details include:
- Exact diagnosis
- Body location
- Tumor thickness if melanoma
- Ulceration status if reported
- Surgical margins
- Lymph-node evaluation
- Stage
- Treatment performed
- Date of treatment
- Previous follow-up schedule
If the original pathology report is unavailable, tell the dermatologist as much as you know rather than assuming the previous lesion was low risk.
High-Risk Surveillance for Expats in Bangkok
Expatriates may have accumulated significant ultraviolet exposure before moving to Thailand.
Risk assessment should therefore consider lifetime history, including previous residence in:
- Australia
- New Zealand
- Europe
- North America
- South Africa
- Other regions with substantial ultraviolet exposure
The surveillance plan should be based on the person’s medical and skin-cancer history rather than simply the number of years they have lived in Bangkok.
Surveillance for Tourists and International Patients
Patients visiting Bangkok temporarily may need:
- Review of a changing lesion
- Follow-up of a previously photographed mole
- Examination after previous skin cancer
- Assessment of a suspicious treatment scar
- A second opinion about whether biopsy is needed
If ongoing follow-up will occur in another country, maintaining clear records becomes especially important.
Where appropriate, patients should keep copies of:
- Consultation notes
- Photographs
- Pathology reports
- Procedure reports
- Follow-up recommendations
What to Expect at Your First High-Risk Surveillance Appointment
A first visit may take more time than a routine follow-up because the dermatologist needs to establish the patient’s baseline.
Important history may include:
- Previous melanoma
- Previous basal cell carcinoma
- Previous squamous cell carcinoma
- Number of previous cancers
- Previous atypical moles
- Family history
- Immune suppression
- Organ transplantation
- Sun exposure
- Previous sunburns
- Outdoor occupation
- Previous pathology results
- Previous mole mapping
- Current concerning lesions
The dermatologist can then determine what type of surveillance is appropriate rather than applying the same plan to every patient.
What Should a Good Surveillance Plan Tell You?
After the consultation, you should understand:
- Why you are considered high risk
- What type of skin cancer you are at risk for
- How often professional examinations are recommended
- Whether dermoscopy is useful
- Whether photography or mole mapping is useful
- Whether lymph nodes need monitoring
- Whether imaging is necessary
- How often to examine your own skin
- Which warning signs require earlier review
- What records should be kept
A surveillance plan should be understandable enough that the patient knows what to do between appointments.
Frequently asked questions
What is high-risk skin cancer surveillance?
It is planned, repeated dermatologic follow-up for people who have a higher risk of developing another skin cancer or recurrence of a previous cancer.
Who needs high-risk skin cancer surveillance?
Common groups include people with previous melanoma, multiple skin cancers, previous basal or squamous cell carcinoma, numerous atypical moles, strong melanoma family history or significant immune suppression.
Is surveillance the same as a routine skin check?
No. Surveillance usually implies an ongoing structured program based on a known elevated risk.
Do melanoma survivors need lifelong skin checks?
Long-term skin follow-up is generally recommended because melanoma can recur and patients are also at increased risk of developing another melanoma.
How often should I be checked after melanoma?
It depends on melanoma stage and individual recurrence risk. Early-stage patients may have less frequent visits than patients with higher-stage disease.
How often should I be checked after basal cell carcinoma?
Annual checks are generally recommended, while some patients may require more frequent surveillance depending on individual risk.
How often should I be checked after squamous cell carcinoma?
At least annual follow-up is recommended, but higher-risk patients often require closer surveillance, particularly in the first few years.
Does having one skin cancer increase the risk of another?
Yes. Previous skin cancer is an important reason for continued skin examination.
Does surveillance examine only the previous cancer site?
No. The entire skin should usually be assessed because a new primary cancer may develop elsewhere.
Are scars from previous skin-cancer surgery checked?
Yes. The treated area is generally inspected for concerning changes.
Are lymph nodes checked?
They may be, particularly after melanoma or certain higher-risk squamous cell carcinomas.
Does every high-risk patient need dermoscopy?
No. It is used selectively according to the type of lesions and individual risk.
What is mole mapping?
It is photographic surveillance that helps identify new or changing lesions over time.
Who benefits most from mole mapping?
It is particularly useful in selected high-risk patients with many moles or atypical moles.
Is mole mapping the same as a full-body skin examination?
No. Photography complements rather than replaces direct clinical examination.
What is sequential dermoscopic monitoring?
It involves photographing a lesion through a dermatoscope and comparing it with later images.
Can every suspicious mole be monitored instead of biopsied?
No. Clearly suspicious or nodular lesions may require prompt biopsy or excision.
Does an abnormal mole always mean melanoma?
No. Many atypical-looking lesions are benign.
What is the ugly duckling sign?
It describes a lesion that looks noticeably different from a patient's other moles.
Should I check my skin between appointments?
Yes. Regular self-examination is especially important for patients with previous melanoma or other skin cancers.
How often should melanoma survivors check their skin?
Monthly self-examination is commonly recommended.
What should I look for during a self-check?
Look for new, changing, bleeding, crusting, rapidly growing or non-healing lesions.
Should I check my scalp?
Yes. The scalp can be difficult to examine without assistance.
Should I check the soles of my feet?
Yes, particularly because melanoma can occur on acral skin including the soles.
Should I check my nails?
Yes. New persistent or changing pigmentation in a single nail may require evaluation.
Does surveillance detect every skin cancer?
No. No surveillance method is perfect, and new lesions can develop between visits.
Can a skin cancer develop between scheduled appointments?
Yes. You should seek earlier review if you notice a concerning change rather than waiting for the next routine visit.
Does high-risk surveillance prevent melanoma?
It does not prevent every melanoma. Its purpose is ongoing monitoring and timely evaluation of suspicious changes.
Do I need routine scans after melanoma?
Not necessarily. Imaging depends on melanoma stage, recurrence risk, symptoms and the treating team's recommendations.
Does every melanoma patient need a positron-emission tomography scan?
No.
Are blood tests necessary for skin-cancer surveillance?
Not routinely for all patients. They may be appropriate in selected advanced cases.
Can basal cell carcinoma return after treatment?
Yes. Recurrence is possible, which is one reason follow-up remains important.
Can squamous cell carcinoma return?
Yes, particularly when the original tumor had higher-risk characteristics.
Can melanoma return many years later?
Yes. Although recurrence is more common in the earlier years after treatment, late recurrence can occur.
What is the difference between recurrence and a new primary melanoma?
Recurrence is return of the original cancer. A new primary melanoma is an entirely new melanoma developing independently.
Can Asian patients develop melanoma?
Yes.
Is skin-cancer surveillance useful for darker skin?
Yes. Surveillance should be adapted to skin type and should include areas such as palms, soles and nails when appropriate.
What records should I bring to a surveillance appointment?
Bring pathology reports, operative reports, previous photographs, mole-mapping records and information about previous cancer staging and treatment.
Can I continue surveillance in Bangkok if my previous cancer was treated abroad?
Yes. Previous medical records can help establish an appropriate ongoing follow-up plan.
Should tourists bring their previous pathology reports?
Yes, particularly if they are seeking follow-up for melanoma or another previous skin cancer.
When should I see a dermatologist before my scheduled follow-up?
Seek earlier review for a rapidly changing lesion, unexplained bleeding, a non-healing sore, a new lump near a previous cancer scar, a new enlarged lymph node or another concerning change.
Related conditions
-
Full Body Skin Examination Full Body Skin Examination A full body skin examination is a head-to-toe assessment of the skin performed to look for suspicious moles, abnormal growths, precancerous changes and signs of skin cancer.

-
Dermoscopy Dermoscopy Dermoscopy is a non-invasive examination technique that allows a dermatologist to inspect skin lesions with greater detail than is possible with the naked eye alone.

-
Mole Check Mole Check Most moles are harmless. However, a new mole, a changing mole, or a spot that looks different from your other moles deserves closer attention.

-
Melanoma Melanoma Melanoma is a serious type of skin cancer that develops from melanocytes, the cells that produce pigment in the skin. Unlike most basal cell carcinomas and many cutaneous squamous cell carcinomas, melanoma has a greater potential to spread to lymph nodes and other organs if it becomes invasive.





























